Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin versus amlodipine in obesity-related hypertension
ChiCTR2000032391Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dapagliflozin and amlodipine in hypertension (HTN) and obesity (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Height, Weight and 17 more. Planned start May 2020; status: not yet recruiting.
02
Drugs
dapagliflozinamlodipine
03
Conditions
hypertension (HTN)obesity
Beyond the preview
Go deeper on ChiCTR2000032391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032391.